How to Get Alprostadil (Caverject/MUSE) in Indiana

What alprostadil is and how it works

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes smooth muscle in the corpus cavernosum, widening the helicine arteries and producing an erection within 5 to 20 minutes. The mechanism is independent of nitric oxide pathways, so it works in men who cannot tolerate or do not respond to phosphodiesterase-5 (PDE5) inhibitors such as sildenafil or tadalafil. The FDA approved Caverject for refractory erectile dysfunction (ED) in 1995, and the key Linet et al. trial published in the New England Journal of Medicine the following year confirmed its clinical profile across 296 men. [1]

In that trial, 94% of injection attempts in the alprostadil group produced a sufficient erection for intercourse compared with 1% in the placebo group (P<0.001). [1] That response rate established alprostadil as the gold-standard second-line therapy for ED when oral agents fail, a position it still holds under the American Urological Association's 2018 guidelines. [2]

MUSE (medicated urethral system for erection) delivers the same active molecule as a 125, 250, 500, or 1 to 000 mcg pellet inserted into the urethra with a small plastic applicator. Absorption through the urethral mucosa is slower than direct intracavernosal injection, producing a more modest but still clinically meaningful response in a subset of men who prefer to avoid needles. [3]

Indiana-specific prescribing rules

Indiana does not restrict alprostadil prescriptions to any single specialty. Any physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) holding an active Indiana license may write the prescription, provided they have conducted an appropriate evaluation. [4] That evaluation may occur in person or, since Indiana expanded its telehealth statute, through a synchronous audio-video visit that meets the standard of care.

Indiana Code 25-1-9.5 governs telehealth practice and requires a real-time interactive encounter before a controlled or prescription-only medication is prescribed for the first time. Alprostadil is not a controlled substance under federal or Indiana law, but it remains a prescription-only product under the Federal Food, Drug, and Cosmetic Act. [5] A provider who sees you via video call, reviews your history, and documents an ED diagnosis may issue a valid Indiana prescription during that same session.

Prior to prescribing, most providers will want, at minimum, a fasting morning testosterone level, a basic metabolic panel, and a hemoglobin A1c if diabetes is suspected. Coagulation studies (PT/INR) are ordered when anticoagulant use is disclosed. These labs can be ordered through any Indiana-licensed laboratory or drawn at a local draw site and reviewed before or during the telehealth visit. [6]

How to get a prescription through telehealth in Indiana

The process follows four concrete steps.

Step 1: Choose a licensed Indiana telehealth provider. HealthRX and several other platforms employ providers holding active Indiana licenses. Confirm licensure on the Indiana Professional Licensing Agency (IPLA) public search before booking. [4]

Step 2: Complete your intake and upload any relevant records. Prior PDE5 inhibitor trials, cardiovascular history, and a medication list are reviewed before your video visit. A provider who sees documented sildenafil failure, for example, has a clearer clinical rationale for proceeding to alprostadil. [7]

Step 3: Attend the synchronous video visit. The provider confirms diagnosis, discusses injection technique or MUSE insertion, reviews contraindications (severe hypotension, bleeding disorders, anatomical deformity such as Peyronie disease that might worsen with injection), and answers questions. The appointment typically runs 20 to 30 minutes.

Step 4: Receive and fill the prescription. The provider transmits the prescription electronically to a pharmacy of your choice. Commercial Caverject and MUSE are stocked at major chain pharmacies. If a compounded formulation is preferred or cost is a concern, the prescription may be sent to an Indiana-licensed 503A compounding pharmacy. [8] Shipping from most compounding pharmacies to an Indiana address takes 2 to 4 business days after the prescription is verified.

Dosing protocol and titration

The FDA label for Caverject specifies starting at 2.5 mcg for neurogenic ED and 5 mcg for vasculogenic or psychogenic ED, with dose increases of 2.5 mcg during subsequent office visits until an erection adequate for intercourse, but lasting no more than 60 minutes, is achieved. [9] Self-injection is then performed at home using the dose established in office. No more than one injection per 24 hours and no more than three injections per week are recommended to reduce the risk of priapism and corporal fibrosis.

MUSE dosing starts at 125 mcg or 250 mcg. If the lower dose produces no response after two properly administered attempts, the provider steps up to 500 mcg or 1 to 000 mcg. [3] Unlike Caverject, MUSE should be used with a constriction ring at the base of the penis to improve penile blood retention; this is detailed in the product labeling. [9]

Penile pain is the most commonly reported adverse effect with intracavernosal alprostadil, occurring in approximately 10.4% of injections in the Linet trial. [1] Prolonged erection (more than 4 hours) or priapism requires prompt medical attention. Indiana residents within driving distance of a major hospital should identify their nearest emergency department before starting therapy, and every patient should receive written instructions on when to seek care. [10]

503A compounding pharmacies in Indiana

A 503A pharmacy compounds medications for individual patients pursuant to a valid prescription. Indiana-licensed 503A pharmacies may prepare sterile alprostadil solutions in strengths that differ from the commercially available 10, 20, or 40 mcg/mL vials, which can reduce per-dose cost substantially. The Indiana Board of Pharmacy oversees 503A compounding facilities operating within the state, and the FDA monitors interstate shipment of compounded sterile preparations. [8]

When selecting a compounding pharmacy, verify that the facility holds current Indiana pharmacy licensure and that its sterile compounding suite has passed an NABP (National Association of Boards of Pharmacy) Pharmacy Verified Websites Program inspection or equivalent accreditation. Unaccredited online pharmacies selling injectable alprostadil without a prescription are operating outside federal law. [5]

Typical compounded alprostadil concentrations prepared by 503A pharmacies include 10 mcg/0.5 mL and 20 mcg/0.5 mL. Some pharmacies offer bi-mix (alprostadil plus papaverine) or tri-mix (alprostadil plus papaverine plus phentolamine) formulations, which may produce a stronger or longer-lasting response for men who plateau on alprostadil monotherapy. [11] Tri-mix is prescribed off-label but is well-documented in the urology literature, with one review in the Journal of Sexual Medicine reporting response rates exceeding 80% in men who did not respond to alprostadil alone. [11]

Insurance coverage and cost in Indiana

Commercial insurance coverage for Caverject and MUSE is variable. Many Indiana Blue Cross Blue Shield, Anthem, and UnitedHealthcare plans classify alprostadil as a specialty medication requiring prior authorization. Standard documentation for prior authorization includes proof of at least two failed PDE5 inhibitor trials at maximum tolerated dose, a diagnosis code (ICD-10 N52.xx for erectile dysfunction), provider attestation of medical necessity, and, in some cases, a urology consult note. [12]

Indiana Medicaid does not cover alprostadil for erectile dysfunction in the general population. Coverage is theoretically available only when the indication is tied to type 2 diabetes complications, and even then approvals are rare. [13] Veterans enrolled in VA health care may access alprostadil through the VA formulary if a VA provider documents the indication; this pathway is independent of Indiana Medicaid.

Without insurance, a single Caverject 20 mcg dual-chamber syringe retails for approximately $80 to $130 at Indiana chain pharmacies, depending on the dispensing location. A compounded alprostadil vial (10 mL, 20 mcg/mL, yielding approximately 20 doses) from a 503A pharmacy typically costs $60 to $90, making the per-dose cost roughly $3 to $5 compared with $80 to $130 for the branded product. [8]

GoodRx and similar discount cards may reduce the Caverject retail price by 15 to 30% at participating Indiana pharmacies. The savings vary by zip code and pharmacy chain.

Transferring an existing alprostadil prescription to Indiana

A patient who relocates to Indiana with an active alprostadil prescription written by an out-of-state provider faces two scenarios. If the prescribing provider holds an Indiana license or a telehealth compact license recognized in Indiana, the prescription remains valid and may be transferred to any Indiana-licensed pharmacy. [4] If the prescriber is not licensed in Indiana, the prescription cannot legally be filled by an Indiana pharmacy, and the patient must establish care with an Indiana-licensed provider before obtaining a new prescription.

Indiana participates in the Interstate Medical Licensure Compact (IMLC), which allows physicians already licensed in compact member states to obtain expedited Indiana licensure. This means a telehealth provider based in another compact state may be eligible to prescribe to Indiana patients with fewer administrative barriers than a fully new license would require. [4]

Transferring a prescription between two Indiana pharmacies is straightforward: the receiving pharmacy contacts the dispensing pharmacy directly, obtains the remaining refills on file, and fills the prescription. Caverject and compounded alprostadil are non-controlled substances, so there are no Schedule II transfer restrictions. [5]

What labs are needed before starting alprostadil

Labs serve two purposes before alprostadil is prescribed. First, they identify reversible causes of ED that might be treated instead of, or alongside, alprostadil. Second, they establish a safety baseline. [6]

The minimum recommended panel at most evidence-based ED clinics includes:

• Morning total testosterone (drawn before 10 a.m.): low testosterone is present in up to 35% of men presenting with ED and is independently treatable. [6]
• Fasting glucose or HbA1c: undiagnosed type 2 diabetes is a common underlying cause of vasculogenic ED. [13]
• Lipid panel: dyslipidemia drives endothelial dysfunction, the same vascular pathway responsible for most organic ED. [7]
• Basic metabolic panel: creatinine and electrolytes identify renal impairment that may affect drug metabolism.
• PSA (men over 45): not required for alprostadil but recommended as part of a complete male health baseline before any testosterone-modifying therapy is added. [6]

A provider may order additional studies (penile Doppler ultrasound, nocturnal penile tumescence testing) if the history suggests a purely vascular origin or if the patient has failed both oral and injectable therapies. These specialist studies are typically performed at a urology office rather than through a telehealth platform.

Side effects and safety considerations

The FDA Caverject label lists the following adverse reactions observed at rates above 1% in clinical trials: penile pain (10.4%), prolonged erection (4%), penile fibrosis (3%), and hematoma at the injection site (3%). [9] Systemic effects are uncommon because most of the drug acts locally, but hypotension has been reported, particularly with MUSE in men who absorb a higher percentage into systemic circulation. [3]

Contraindications listed in FDA labeling include: conditions predisposing to priapism (sickle cell anemia, multiple myeloma, leukemia), anatomical deformation of the penis that could worsen with repeated injection, and use in patients with penile implants. [9] Alprostadil is not recommended for sexual activity in men whose partners are pregnant unless a condom is used, because prostaglandin E1 can cause uterine contractions. [9]

Drug interactions with alprostadil are limited. Anticoagulants increase bruising and hematoma risk at the injection site. Vasoactive agents such as antihypertensives may compound systemic blood pressure lowering with MUSE. The American Urological Association's clinical guidance notes that alprostadil should not be combined with other vasoactive agents for ED without specialist oversight. [2]

Finding a provider in Indiana who prescribes alprostadil

Indiana has approximately 180 board-certified urologists practicing across the state, concentrated in Indianapolis, Fort Wayne, Evansville, and South Bend. [4] A referral from a primary care provider is the traditional route, though it is not legally required. Most urology offices will schedule a new ED consultation without a referral and can initiate in-office titration on the same day if time permits.

Telehealth providers, including HealthRX, conduct the evaluation remotely and transmit the prescription to the pharmacy or compounding pharmacy of your choice, eliminating the need for an in-person titration visit for patients who are comfortable with self-injection training via video. Self-injection training by video is accepted clinical practice for patients who are motivated and who have reviewed written technique guides; one 2022 review in Translational Andrology and Urology confirmed non-inferior patient satisfaction for remote-trained vs. in-office-trained injection patients in a cohort of 148 men. [14]

Nurse practitioners and physician assistants practicing in Indiana under a collaborative agreement with a supervising physician may prescribe alprostadil independently in most clinical settings. Indiana NP prescriptive authority is governed by Indiana Code 25-23-1-19.4, which allows NPs to prescribe prescription-only medications within their scope of practice without a written collaborative agreement as of July 2023. [4]

Step-by-step: Getting alprostadil from HealthRX in Indiana

1. Complete the online intake form (5 minutes). List all current medications, prior PDE5 inhibitor use, and cardiovascular history.
2. Order labs at a local draw site if you have not had testosterone and metabolic labs within the past 6 months.
3. Book a 20-minute video visit with a HealthRX provider holding an Indiana license.
4. During the visit, the provider reviews your labs and history, confirms the indication, discusses dosing, and answers injection or MUSE technique questions.
5. The prescription is sent electronically to your preferred Indiana pharmacy or to a HealthRX-partnered 503A compounding pharmacy.
6. Medication arrives within 2 to 4 business days. A follow-up message from your provider at the 2-week mark confirms response and allows dose adjustment if needed.

Indiana residents outside major metro areas benefit from telehealth access most directly: a man in rural Bartholomew County, for example, would otherwise face a 45-to-90-minute drive to reach the nearest urology practice. The telehealth visit eliminates that barrier entirely while meeting the same clinical standard. [4]

Starting dose for first home use: the dose established during in-office or telehealth titration. Do not exceed the prescribed dose on the first home attempt. If no erection occurs within 60 minutes, do not repeat the injection on the same day. Contact your provider before the next attempt.